Clinical Trial Update: A Feasibility Trial of OCM Supplements for the Treatment of NAFLD [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase feasibility trial evaluating OCM dietary supplements for non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• OCM Supplements

Snippet

Sponsor: Duke University | Conditions: NAFLD | EARLY_Phase 1 | Status: COMPLETED